Defunct Company
Total Trials
20
As Lead Sponsor
7
As Collaborator
13
Total Enrollment
1,125
NCT01763710
Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2012
Completion: Dec 31, 2015
NCT03090906
Soft Tissue Volume Gain and Stability Comparing Palate and Tuberosity
Phase: N/A
Role: Collaborator
Start: Apr 30, 2015
Completion: Aug 31, 2017
NCT02628379
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
Start: May 31, 2015
Completion: Mar 31, 2017
NCT03422458
The Impact of Immediate Implant Placement on Alveolar Ridge Preservation Techniques
Start: Jan 1, 2016
Completion: Apr 11, 2018
NCT03077061
Peri-implantitis - Reconstructive Surgical Therapy
Start: Apr 1, 2017
Completion: Mar 14, 2026
NCT03163602
Surgical Treatment of Peri-implantitis
Start: May 15, 2017
Completion: Sep 6, 2021
NCT03564301
Metronidazole as an Adjunct of Non- Surgical Treatment of Peri-implantitis
Phase: Phase 4
Start: Mar 3, 2018
Completion: Dec 22, 2020
NCT03620331
Surgical Treatment of Peri-implantitis With and Without an Initial Non-surgical Approach
Start: Jul 1, 2018
Completion: Nov 30, 2020
NCT06377722
Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer
Start: Nov 1, 2018
Completion: Aug 9, 2022
NCT04210596
Connective Tissue Graft Versus Collagen Matrix
Start: Sep 1, 2019
Completion: Dec 31, 2025
NCT04253145
Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer.
Phase: Phase 1/2
Start: Dec 13, 2019
Completion: May 31, 2025
NCT04134000
Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)
Phase: Phase 1
Start: Feb 3, 2020
Completion: Sep 30, 2024
NCT04494958
Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer
Start: Nov 18, 2020
Completion: Dec 14, 2023
NCT04440241
Regenerative Surgical Treatment of Peri-implant Defects
Start: Apr 1, 2021
Completion: Dec 1, 2022
NCT05211115
Autogenous vs. Xenogeneic Peri-implant Soft Tissue Grafts Placed in Full vs. Split Thickness Flaps
Start: Jan 24, 2022
Completion: Dec 1, 2024
NCT05655247
Partial-thickness/Non-advanced vs. Full-thickness/MCAT Tunnelling for the Treatment of Multiple Gingival Recessions
Start: Jan 5, 2023
Completion: Dec 30, 2027
NCT05844475
Buccal Graft + Collagen Matrix Versus Free Gingival Graft for Keratinized Mucosa Augmentation at Implant Sites
Start: Apr 13, 2023
Completion: Dec 21, 2025
NCT05563558
Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
Start: May 5, 2023
Completion: Nov 1, 2026
NCT06315348
Effect on Periodontal Phenotype of Flapless Piezoincission During Orthodontic Treatment
Start: Apr 30, 2024
Completion: Apr 30, 2025
NCT06582628
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
Start: Jul 5, 2024
Completion: Oct 31, 2027